Additional Resources

AASLD 2014 Presentations: Editor's Choice

Dr. Edward Lebovics Abstracts selected by Dr. Edward Lebovics, Director of the Sarah C. Upham Division of Gastroenterology & Hepatobiliary Diseases at New York Medical College in Valhalla, New York.

Abstract 77
Treatment with Interferon (IFN) and Ribavirin (RBV)-Free Regimens with Ledipasvir (LDV) and Sofosbuvir (SOF) Improves Patient-Reported Outcomes (PRO) for Patients with Genotype 1 (GT1) Chronic Hepatitis C (CH-C): Results from the ION-1, 2 and 3 Clinical Trials

Zobair Younossi et al. Hepatology Special Issue: The 65th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2014. Volume 60, Issue Supplement S1, pages 235A–236A, October 2014.

For more information on this study, click here.

HCV Treatment and Screening Guidelines